Literature DB >> 26614896

Clinical features and diagnosis of hairy cell leukemia.

Graeme R Quest1, James B Johnston2.   

Abstract

Significant advances in the diagnosis and treatment of hairy cell leukemia (HCL) have recently been made. Improved distinction of HCL from its mimics though clinical presentations, morphologic and immunophenotypic features, and more recently molecular biology, has highlighted marked differences in treatment response and overall prognosis between these disorders. As our understanding of the unique pathobiology of HCL has grown, exciting new avenues of treatment as well as insight into immune function have been obtained. This review provides an overview of the clinical features and diagnostic attributes of HCL, with contrast to other mature B cell lymphoproliferative disorders with overlapping features.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRAF V600E; Clinical features; Diagnosis; Hairy cell leukemia; Immunophenotyping

Mesh:

Substances:

Year:  2015        PMID: 26614896     DOI: 10.1016/j.beha.2015.10.017

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  9 in total

1.  Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine.

Authors:  Anamarija M Perry; Kant Matsuda; Vikram Wadhwa; Donna Hewitt; Muhamad Almiski; James B Johnston; Versha Banerji
Journal:  Blood Adv       Date:  2017-05-30

2.  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.

Authors:  Fergün Yılmaz; Dilan Atilla; Nagihan Akkaş; Hale Bülbül; Nur Soyer; Derya Demir; Demet Kiper; Aylin Avcı; Filiz Vural; Güray Saydam; Fahri Şahin; Mine Hekimgil; Nazan Özsan; Raika Durusoy; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-13       Impact factor: 0.900

Review 3.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

Review 4.  Update on hairy cell leukemia.

Authors:  Robert J Kreitman; Evgeny Arons
Journal:  Clin Adv Hematol Oncol       Date:  2018-03

5.  Hairy cell leukemia: a case report of atypical presentation without splenomegaly.

Authors:  Mona Alfaraj; Hussain Alsaeed
Journal:  Blood Res       Date:  2017-06-22

Review 6.  Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples.

Authors:  Esther Diana Rossi; Maurizio Martini; Tommaso Bizzarro; Fernando Schmitt; Adhemar Longatto-Filho; Luigi Maria Larocca
Journal:  Oncotarget       Date:  2017-01-10

Review 7.  Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2020-08-03

8.  Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report.

Authors:  Maria Mitsogianni; Nikolaos Mitsimponas; Felipe Crespo; Karl Axel Hartmann; Bernd Klosterhalfen; Sabine Haase; Aristoteles Giagounidis
Journal:  Case Rep Oncol       Date:  2018-02-14

9.  Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment.

Authors:  Deborah Soong; Priyadarshini Kumar; Karan Jatwani; Jae Park; Ahmet Dogan; Justin Taylor
Journal:  JCO Precis Oncol       Date:  2021-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.